Skip to content
Disability, Medical Health Aged Care

Aphasia recovery professor scoops international award

La Trobe University 2 mins read

A La Trobe professor has been awarded the Robin Tavistock 2024 award for her important contribution to the field of aphasia, a significant communication disability following stroke and other brain injuries where people can have difficulty speaking, reading, writing, and understanding language and numbers.

Professor Miranda Rose, Director of La Trobe’s Centre of Research Excellence in Aphasia Recovery and Rehabilitation, received the prestigious award presented annually to a person or group who has made a significant international contribution to the field of aphasia.

The award is named after Robin Tavistock, the 14th Duke of Bedford who founded The Tavistock Trust for Aphasia.

“I feel honoured and very humbled to receive this international award – it reflects the hard work and generous collaboration of the many national and international researchers, clinicians, and people with lived experience of communication disability that I have been so fortunate to work with,” Professor Rose said.

Professor Rose, who set up the Centre in 2019, was lead investigator in the largest comparison trial of aphasia rehabilitation to date, which examined outcomes from constraint-induced and multi-modality aphasia treatments.

The team found that the intervention they developed, called Multi-modality Aphasia Therapy (M-MAT), was more effective than constraint therapy and usual care for improving quality of life for people with aphasia following a stroke. M-MAT is provided by a speech pathologist in small groups of people with aphasia.

Following the trial M-MAT is being developed for telehealth delivery. M-MAT has been successfully trialled in Canada and Japan and will soon be trialled in Brazil.

Professor Rose and her co-design team created the new Communication Connect web platform, which helps people living with aphasia and communication disabilities after traumatic brain injury to communicate better and live well once they leave rehabilitation programs.

The Communication Connect web platform is AI enabled so solutions to challenges can be personalised and customised to the user’s needs. The platform will undergo a pilot trial through Bendigo Health this year.

Professor Rose said the platform contained information about rehabilitation and self-management options, links to apps for self-managed communication therapy and bespoke solutions such as a mood tracker that can support the person to track their mood and aims to reduce the possibility of developing depression or social isolation.


Contact details:

Elaine Cooney
[email protected]
0487 448 734

More from this category

  • Medical Health Aged Care
  • 30/04/2026
  • 23:25
Sinovac Biotech Ltd.

SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024

BEIJING--BUSINESS WIRE-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the…

  • Medical Health Aged Care
  • 30/04/2026
  • 22:10
Merck

Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations

Significant unmet need remains for 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burden Enpatoran, an…

  • Contains:
  • Medical Health Aged Care, Women
  • 30/04/2026
  • 22:04
ANZGOG | WomenCan

Actress Paula Duncan leads heartfelt campaign for gynaecological cancer research after sister’s death

MEDIA RELEASE For Immediate release Actress Paula Duncan leads heartfelt campaign for gynaecological cancer research after sister's death After the passing of her sister, acclaimed Australian actress Carmen Duncan, Paula Duncanis turning grief into action,driving a powerful campaign to raise funds for life-saving research into gynaecological cancers. Carmen Duncan died in 2019 at age 76 from vaginal cancer, a rare and aggressive disease, after surviving breast and bowel cancers. Her death highlights a confronting reality: despite medical advances, outcomes for many gynaecological cancers have barely improved in decades. “If you have experienced the devastation of gynaecological cancer, you will understand…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.